Join us at ASTMH's Annual Meeting in National Harbor this November! Stop by our booth and meet some of our experts!

The end-of-phase 2 (EOP2) meeting with FDA is a critical milestone in your development program and likely the most important interaction you will have with the Agency. Getting the most from this meeting can help successfully launch your phase 3 program and help you begin preparing for your marketing application (NDA/BLA) submission. This webinar will […]

Next month we'll be at the 3rd Pan American Parkinson's Disease and Movement Disorders Congress in Miami! Will we see you there?

Boston, here we come! We can’t wait to attend the 8th Annual Neurodegenerative Drug Development Summit. Will we see you there?

We can't wait to see what PharmaSug has in store for us this year!

There's so much to see and do at the Gene Therapy for Rare Disorders Conference in Beantown. Make sure you stop by our booth to see us!

We're looking forward to seeing you at OCT West Coast. Stop by to say hello!

Nothing could be finer than to be in Carolina for OCT Southeast! Come visit us in our hometown of Durham, NC. We can't wait to see you.

DIA is back and better than ever! Come join us!

Kristin Gabor and Joseph Watson are excited to moderate the roundtable: Regulatory Flexibility: FDA’s structured benefit - risk paradigm as a strategic guide for orphan product marketing authorization at the World Orphan Drug Congress in Maryland. Be sure to register and join us!

If you are attending SCDM (like we are), be sure to check out the panel discussion, " Decentralized Clinical Trials: Developing Actionable Strategies & Skills Needed to Navigate the Data Wild West" featuring Heather Kopetskie,  Rho's Director of Biostatistics. This discussion in on demand for attendees until the end of the conference, which runs until […]